Peritransplant Soluble CD30 as a Risk Factor for Slow Kidney Allograft Function, Early Acute Rejection, Worse Long-Term Allograft Function, and Patients’ Survival
Table 3
Outcomes of early and late posttransplant period.
Outcomes
Recipients,
Delayed graft function, n (%)
9 (20.0)
Slow graft function, n (%)
7 (15.6)
Acute rejection episodes during follow-up, n (%)
12 (26.7)
Very early (0–7th day), n (%)
5 (11.1)
Early (the 8th day–6 months), n (%)
4 (8.9)
Late (>6 months), n (%)
3 (6.7)
Pyelonephritis episodes during follow-up, n (%)
7 (15.6)
Early (the 8th day–2 months), n (%)
5 (11.1)
Late (>6 months), n (%)
2 (4.4)
Death with functioning graft during follow-up, n (%)
4 (8.9)
Graft failure during follow-up, n (%)
6 (13.3)
n: number of patients investigated. Numbers (percentages).